SeQuent Please Neo (BBraun Medical) is a balloon catheter for percutaneous transluminal coronary angioplasty. The balloon is coated with the antimitotic drug paclitaxel, with the aim of reducing ...

The B. Braun Group of Companies is the worldwide market leader in drug-coated PTCA technology. BIS received FDA Breakthrough Designation for the SeQuent Please ReX in 2019. About B. Braun ...

The B. Braun Group of Companies is the worldwide market leader in drug-coated PTCA technology. BIS received FDA Breakthrough Designation for the SeQuent Please ReX in 2019.

The B. Braun Group of Companies is the worldwide market leader in drug-coated PTCA technology. BIS received FDA Breakthrough Designation for the SeQuent Please ReX in 2019.

“The paclitaxel-coated SeQuent Please PTCA balloon catheter has a proven track record of safety and efficacy for BMS- and DES-ISR in randomized clinical trials as well as in the largest ...

SeQuent Please ReX is the latest generation coronary drug-coated balloon (DCB) catheter developed by B. Braun, the worldwide market leader in drug-coated PTCA catheters.

By B. Braun Medical Inc., Infraredx, Nipro Company BIS Logo By Daily Local | [email protected] PUBLISHED: March 31, 2021 at 6:08 a.m. | UPDATED: August 25 ...

BETHLEHEM, Pa., March 31, 2021 /PRNewswire/ — B. Braun Interventional Systems Inc. (BIS) announced today that they will collaborate with Infraredx, a Nipro Company, to accelerate the U.S. Foo… ...